SOPHiA GENETICS (SOPH) Cash from Operations (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Cash from Operations data on file, last reported at 8141000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations rose 22.64% year-over-year to 8141000.0; the trailing twelve-month figure through Dec 2025 stood at 35693000.0 (up 18.84% YoY), and the FY2025 full-year result was 35693000.0, up 18.84% from the prior year.
• Cash from Operations advanced to 8141000.0 in Q4 2025, from 8734000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 8113000.0 in Q2 2025 to a low of 23088000.0 in Q3 2022.
• A 5-year average of 13056300.0 and a median of 11784000.0 in 2023 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations slumped 71.39% in 2022 and surged 44.04% in 2023, its largest moves.
• Tracing SOPH's Cash from Operations over 5 years: stood at 15419000.0 in 2021, then grew by 28.85% to 10971000.0 in 2022, then dropped by 14.4% to 12551000.0 in 2023, then increased by 16.15% to 10524000.0 in 2024, then increased by 22.64% to 8141000.0 in 2025.
• Business Quant data shows SOPH's Cash from Operations at 8141000.0 in Q4 2025, 8734000.0 in Q3 2025, and 8113000.0 in Q2 2025.